Reach Us 
+44 7460731551
+44 7460731551Abstract
Impact of Fingolimod on Multiple Sclerosis
Fingolimod could be a sphingosine-1-phosphate receptor modulator that sequesters liquid body substanceocytes in lymph nodes preventing them from conducive to a reaction reaction. it's been reportable to scale back the speed of relapses in relapsing-remitting disseminated multiple sclerosis by or so common fraction over a biennial amount. Fingolimod was shown to be effective in experimental reaction rubor, six AN animal model of disseminated multiple sclerosis (MS), and later investigated in 2 clinical trial clinical trials for relapsingremitting (RR)MS. seven In these trials, fingolimod was incontestable to be a secure and effective drug.
Author(s):
Mamatha Dereddy*
Abstract | Full-Text | PDF
Share this
Annals of Clinical and Laboratory Research peer review process verified at publons
Abstracted/Indexed in
- Google Scholar
- Genamics JournalSeek
- China National Knowledge Infrastructure (CNKI)
- CiteFactor
- Directory of Research Journal Indexing (DRJI)
- Publons
- Secret Search Engine Labs
- Euro Pub
Open Access Journals
- Aquaculture & Veterinary Science
- Chemistry & Chemical Sciences
- Clinical Sciences
- Engineering
- General Science
- Genetics & Molecular Biology
- Health Care & Nursing
- Immunology & Microbiology
- Materials Science
- Mathematics & Physics
- Medical Sciences
- Neurology & Psychiatry
- Oncology & Cancer Science
- Pharmaceutical Sciences